Interesting that article was published one day after topline R-I results came out on Sept 24, 2018. Still not a huge uptake in V scripts until label expansion came in late Dec 2019. They accelerated until March 2020, when after the DuDisaster Amarin started to curtail sales and marketing expenses. It has been a slow ride down since for US scripts and anxiously awaiting next earnings report to see how made the CVS drop has made it.
Market Data 
Markets 
AI
